270 related articles for article (PubMed ID: 12832317)
21. Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide.
Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
Int J Clin Pract; 2005 Aug; 59(8):891-4. PubMed ID: 16033608
[TBL] [Abstract][Full Text] [Related]
22. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
Bakowski D; Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
[TBL] [Abstract][Full Text] [Related]
23. Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population.
Nakamura M; Endo H; Nasu M; Arakawa N; Segawa T; Hiramori K
Heart; 2002 Feb; 87(2):131-5. PubMed ID: 11796549
[TBL] [Abstract][Full Text] [Related]
24. The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients.
Valle R; Bagolin E; Canali C; Giovinazzo P; Barro S; Aspromonte N; Carbonieri E; Milani L
Eur J Echocardiogr; 2006 Jan; 7(1):40-4. PubMed ID: 15886060
[TBL] [Abstract][Full Text] [Related]
25. B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients.
Albertini JP; Cohen R; Valensi P; Sachs RN; Charniot JC
Diabetes Metab; 2008 Sep; 34(4 Pt 1):355-62. PubMed ID: 18599336
[TBL] [Abstract][Full Text] [Related]
26. N-terminal pro-B-type natriuretic peptide: an independent marker for coronary artery disease in asymptomatic diabetic patients.
Cosson E; Nguyen MT; Pham I; Pontet M; Nitenberg A; Valensi P
Diabet Med; 2009 Sep; 26(9):872-9. PubMed ID: 19719707
[TBL] [Abstract][Full Text] [Related]
27. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
[TBL] [Abstract][Full Text] [Related]
28. Electrocardiogram and B-type natriuretic peptide as screening tools for left ventricular systolic dysfunction in a population-based sample of 75-year-old men and women.
Hedberg P; Lönnberg I; Jonason T; Nilsson G; Pehrsson K; Ringqvist I
Am Heart J; 2004 Sep; 148(3):524-9. PubMed ID: 15389243
[TBL] [Abstract][Full Text] [Related]
29. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
30. Brain Natriuretic Peptide and Particular Left Ventricle Segment Asynergy Associated with Cardioembolic Stroke from Old Myocardial Infarction.
Hosomi N; Yoshimoto T; Kanaya Y; Neshige S; Hara N; Himeno T; Kono R; Takeshima S; Takamatsu K; Ota T; Miyamoto Y; Yasuda K; Shimoe Y; Ota T; Kuriyama M; Matsumoto M
J Stroke Cerebrovasc Dis; 2016 May; 25(5):1165-1171. PubMed ID: 26922130
[TBL] [Abstract][Full Text] [Related]
31. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
Ang DS; Kong CF; Kao MP; Struthers AD
Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of B-type natriuretic peptide for assessment of left ventricular function in patients with chronic kidney disease.
Soleimani A; Nasiri O; Nikoueinejad H; Mianehsaz E; Yousefzade M; Foroozanfard F; Tabatabaizadeh M; Moraveji SA; Rajali M
Iran J Kidney Dis; 2011 Jul; 5(4):242-7. PubMed ID: 21725181
[TBL] [Abstract][Full Text] [Related]
33. [Validity and usefulness of B-type natriuretic peptide (BNP) for early detection of left ventricular dysfunction in high-risk patients in primary care].
Lobos Bejarano JM; Horrillo García C; González-González AI; Castellanos Rodríguez A; Díaz Sánchez S; Castellanos Maroto J; Rodriguez-Barrientos R; García-Fernández MA
Aten Primaria; 2012 Jan; 44(1):13-9. PubMed ID: 21636177
[TBL] [Abstract][Full Text] [Related]
34. Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus.
Salem M; El Behery S; Adly A; Khalil D; El Hadidi E
Pediatr Diabetes; 2009 Dec; 10(8):513-21. PubMed ID: 19708908
[TBL] [Abstract][Full Text] [Related]
35. Preoperative plasma B-type natriuretic peptide (BNP) identifies abnormal transthoracic echocardiography in elderly patients with traumatic hip fracture.
Pili-Floury S; Ginet M; Saunier L; Besch G; Bartholin F; Chopard R; Boillot A; Mebazaa A; Samain E
Injury; 2012 Jun; 43(6):811-6. PubMed ID: 22029947
[TBL] [Abstract][Full Text] [Related]
36. The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction- cost-effectiveness in relation to open access echocardiography.
Sim V; Hampton D; Phillips C; Lo SN; Vasishta S; Davies J; Penney M
Fam Pract; 2003 Oct; 20(5):570-4. PubMed ID: 14507800
[TBL] [Abstract][Full Text] [Related]
37. Pericardial fluid and serum biomarkers equally predict ventricular dysfunction.
Amjad S; Sami SA; Basir MN; Hameed K; Fujita M; Ahmad HR
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):160-5. PubMed ID: 24532613
[TBL] [Abstract][Full Text] [Related]
38. Brain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.
Magnusson M; Jovinge S; Shahgaldi K; Israelsson B; Groop L; Melander O
Cardiovasc Diabetol; 2010 Jan; 9():2. PubMed ID: 20078898
[TBL] [Abstract][Full Text] [Related]
39. B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.
Gallagher J; Watson C; Zhou S; Ryan F; Ledwidge M; McDonald K
Am J Hypertens; 2018 Jan; 31(2):228-234. PubMed ID: 29036547
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of brain natriuretic peptide as marker of left ventricular dysfunction and hypertrophy in the population.
Luchner A; Burnett JC; Jougasaki M; Hense HW; Heid IM; Muders F; Riegger GA; Schunkert H
J Hypertens; 2000 Aug; 18(8):1121-8. PubMed ID: 10954005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
